legendary

260 posts

legendary

legendary

@doshunkoss

I

Katılım Şubat 2026
4 Takip Edilen11 Takipçiler
Hardik Shah
Hardik Shah@AIStockSavvy·
📊 𝐀𝐍𝐀𝐋𝐘𝐒𝐓 𝐀𝐋𝐄𝐑𝐓: TD Cowen Raises Price Target on $HIMS 𝐇𝐢𝐦𝐬 & 𝐇𝐞𝐫𝐬 𝐇𝐞𝐚𝐥𝐭𝐡 𝐈𝐧𝐜. to $𝟐𝟓 from $17 — Increase of 𝟒𝟕%
Hardik Shah tweet media
English
1
3
62
10.7K
Arthritisfinger
Arthritisfinger@arthritisfinger·
@otigart The more I study peptides the more bullish I get on $HIMS 2026 is going to be truly amazing.
English
1
0
3
330
Antonio Linares
Antonio Linares@alc2022·
I once said $HIMS had 100X potential, but I was wrong. Demand for peptides are going vertical. A guy vibecoded his dog back to life. We are on course to cure cancer, Alzheimer's and Parkinson's and any other disease with a single prompt. 100X was sandbagging.
English
25
23
477
75.2K
Jordan Carlisle
Jordan Carlisle@jordantcarlisle·
Whoop just launched a $299 blood biomarker panel for women's health. 11 hormonal markers. AI-powered action plans. Respect the move. But notice the pattern: Whoop deepens its own stack instead of integrating across your ecosystem. Your Whoop blood panel doesn't talk to your Oura sleep data. Your CGM glucose patterns don't inform your recovery scores. Your genetics report sits in a PDF nobody reads. Every health tech company is building a deeper silo. Nobody's building the bridge. That bridge — connecting wearables + bloodwork + genetics + your lived experience into one coherent picture — is where the real intelligence emerges. What's your most underused health data source right now?
English
12
3
24
4.4K
Brigham Buhler
Brigham Buhler@ferrisbuhler81·
Great conversation with @joerogan thank you for having me on again. Back on the show talking peptides, broken healthcare, and why the future looks very different from the system we have today. The system manages sickness… the future creates health.
Brigham Buhler tweet media
English
41
50
1.3K
41.2K
Dr. Cameron Maximus🤴🏻 🥷🏻 🧙🏻‍♂️ 🤵‍♂️
On @TBPN, I announced Maximus' two patents on our proprietary protocols: oral & topical testosterone + enclomiphene. Instead of testosterone REPLACEMENT therapy (TRT), we invented testosterone REINFORCEMENT Maintaining & maxxing your natural T without injections or infertility.
English
9
6
86
9.2K
Fundamental Investing
Fundamental Investing@Investinc_Intel·
Does someone know something… peptides? $HIMS
Fundamental Investing tweet media
English
5
4
79
4.7K
Travis Hoium
Travis Hoium@TravisHoium·
$HIMS Analysts are expecting a 22.4% Y/Y growth rate at Hims & Hers in Q4 2026. That might be wrong by a wide margin because: - Eucalyptus acquisition ($100M+ per Q) - Novo deal - Peptide launch later in 2026 I don't make models, but $1 billion in revenue in Q4 2026 (62% growth both organic and acquired) doesn't seem out of the question in an optimistic scenario.
Travis Hoium tweet media
English
4
1
62
4.3K
Mathias Lien
Mathias Lien@mathias_lien·
@doshunkoss @DividendExcess Du endrer skattekortet ditt for 2026. Der kan du velge om du vil endre tabell du trekkes etter eller om du vil sette en prosentssats selv.
Norsk
1
0
0
46
Excession
Excession@DividendExcess·
Skatteetaten har krevd for mye i fjor igjen. Heldigvis blir det rett nå. Skulle fått avkastning fra skatteetaten si.
Excession tweet media
Norsk
8
0
49
16.5K
Joel
Joel@growthrapidly·
$HIMS one year from now: “I can’t believe this was only a $5B market cap…”🚀
Joel tweet media
English
4
1
101
9.8K
PilgrimAngler
PilgrimAngler@PilgrimAngler·
@doshunkoss @alc2022 Peptides are not FDA approved and thus can’t be obtained anywhere currently other than 1) grey market or 2) clinical trials.
English
1
0
2
93
TrendSpider
TrendSpider@TrendSpider·
$BABA Capitulation finder sniped the bottom 🎯 Now the volume gap has to answer
TrendSpider tweet media
English
15
28
295
35K
Dr. Marty Makary
Dr. Marty Makary@DrMakaryFDA·
Today: another action to stop unnecessary animal testing. We can do better.
English
191
279
1.7K
68.1K